Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Biocept Inc (EM) BIOCQ

Healthcare Diagnostics & Research Medical Instruments & Supplies
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (EXPM:BIOCQ)

Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept's CNSide(TM) Assay to Evaluate Patients with Leptomeningeal Metastases

Business Wire September 21, 2023

Biocept Signs CNSide(TM) Licensing Agreement with Plus Therapeutics

Business Wire September 8, 2023

Biocept to Participate in the H.C. Wainwright Global Investment Conference

Business Wire September 5, 2023

Biocept to Hold Business Update Conference Call on August 30, 2023

Business Wire August 25, 2023

Biocept Reports Second Quarter 2023 Financial Results

Business Wire August 14, 2023

Biocept's CNSide(TM) Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference

Business Wire August 14, 2023

Biocept Announces the Passing of Board Chair M. Faye Wilson

Business Wire July 13, 2023

Biocept Names Antonino Morales as President and Chief Executive Officer

Business Wire June 20, 2023

Biocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023

Business Wire June 14, 2023
View More News ››

Opinion & Analysis (EXPM:BIOCQ)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:BIOCQ)

BIOC / BIOCQ..and yes..I got caught in the NASDAQ delisting

I started a small position and failed to notice the 8K filed on EDGAR 10/16/23  Totally blind-sided Me ..no position Inline XBRL...
Iseneschal - October 26, 2023

BIOC....Delisted from NASDAQ this a.m....

Now BIOCQ Surprise surprise.....Just another "Curveball" thrown at the unsuspecting Shareholders will be the last to know...
Iseneschal - October 25, 2023

BIOC ....Check the volume increase during the last

3 days trading
Iseneschal - October 19, 2023

BIOC ....is this going to breakout and into....

The Gap ???? Time will tell.....I doubt it JMHO
Iseneschal - October 19, 2023

BIOC....On watch list

61 cents
Iseneschal - October 19, 2023

RE:Action here for tomorow

Do you have a position or are you just looking ???? In English ....please : )
Iseneschal - October 18, 2023
View more Bullboard ››

Tidal Care Inc.

Tidal Care Inc.

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ...
View More »

Podcasts